[The effect of administration of prednisolone and methandrostenolone on certain pathochemical changes in experimental heliotrin hepatitis].
D000470:Alkaloids; D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D001835:Body Weight; D056486:Chemical and Drug Induced Liver Injury / Q000139:chemically induced*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006003:Glycogen / Q000097:blood; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000097:blood / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D008696:Methandrostenolone / Q000627:therapeutic use*; D010101:Oxygen Consumption; D010936:Plant Extracts; D010939:Plant Poisoning / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use*; D011506:Proteins / Q000378:metabolism; D051381:Rats
D000470:Alkaloids; D001798:Blood Proteins; D005230:Fatty Acids, Nonesterified; D008074:Lipoproteins; D010936:Plant Extracts; D011506:Proteins; D006003:Glycogen; D011239:Prednisolone; D008696:Methandrostenolone
Vliianie vvedeniia prednizolona i metandrostenolona na nekotorye patokhimicheskie sdvigi pri éksperimental'nom geliotrinnom gepatite.